Key sentence from the paper: “… treatments with radiotherapy…and ADT…were each independently associated with increased risk of coronary heart disease, sudden cardiac death, fracture, and fracture requiring hospitalization.”
Read MoreDoes ADT cause dementia?
Key sentence from the paper: “Our study extends previous work supporting an association between use of ADT and Alzheimer disease and suggests that ADT may more broadly affect neurocognitive function.”
Read MoreDoes the benefit of ADT vary depending on comorbidities and other risk factors one has?
Key sentence from the paper: “The risk of [prostate cancer specific mortality] significantly decreased with the addition of ADT in the setting of high-dose [radiation therapy] for men with intermediate- or high-risk [prostate cancer] with a low, but not a high [competing mortality] score.”
Read MoreIs free testosterone better than total testosterone for indicating prostate cancer progression?
Key sentence from the paper: “The role of serum [total testosterone] measurement during ADT remains unclear and here we have generated the hypothesis that [free testosterone] determination at 6-month is a better surrogate than [total testosterone] to predict [castrate-resistant prostate cancer] in patients with no metastatic disease.”
Read MoreDoes one’s testosterone level, when starting ADT, have any effect on their long-term survival?
Key sentence from the paper: “…in men with known [coronary artery disease], only those with baseline low and lower 1/3 of the normal testosterone had a significantly higher [overall mortality] when they received ADT >6months compared with when they did not.”
Read MoreIf one is on short-term ADT, does the duration of concurrent anti-androgen matter?
Key sentence from the paper: “… for men with no or minimal comorbidity, it appears that the delivery of full versus dose-reduced [anti-androgens] was not associated with prolonged survival…suggesting that supplementing the LHRH agonist therapy with and [anti-androgen] for ~4 rather than 6 months may be sufficient to minimize death from [prostate cancer] and prolong survival as compared with no ADT use.”
Read MoreWhat is the best exercise program to avoid metabolic syndrome while on ADT?
Key sentence from the paper: “… Although large–scale RCTs are needed to ascertain the precise exercise prescription necessary to improve [metabolic syndrome] factors arising from ADT administration, patients can still benefit from consistent exercise as improvements in muscle mass, strength, physical function and psychological well-being have been demonstrated.”
Read MoreDoes switching LHRH agonist help when an LHRH agonist stops working?
Key sentence from the paper: “… we did not find any indication that second-line LHRH analogues resulted in further decrease in PSA even under equivalent low LH and testosterone levels prior to and after switching therapy.”
Read MoreIs ADT more risky of African American than Caucasian men?
Key sentence from the paper: “[T]here appears to be an increased risk of death among AA [African American] men with low-risk or favorable intermediate-risk PC [prostate cancer] exposed to a short course of neoadjuvant ADT. Therefore, the use of ADT in AA men should be reserved for treating higher risk PC.”
Read MoreADT reduces men’s quality of life.
Key sentence from the paper: “Overall, QoL [quality of life ] is significantly affected within 12 months of commencing ADT for prostate cancer in men undergoing ADT, above that for a cancer diagnosis alone, prostate cancer progression or radiotherapy.”
Read More